NCT02969421 is a NA clinical trial of Cough method for placement of tenaculum in Pain, sponsored by Duke University.

Who is sponsoring NCT02969421?

NCT02969421 is sponsored by Duke University.

What drugs are being tested in NCT02969421?

Interventions in NCT02969421: Cough method for placement of tenaculum, Slow Tenaculum Placement of tenaculum.

Is NCT02969421 still recruiting?

NCT02969421 is currently completed. Last updated 18 March 2019.

Are results published for NCT02969421?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2019-03-18 · How we verify

NCT02969421

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pain Perception With Tenaculum Placement

Completed NA Results posted Last updated 18 March 2019

What this trial tests

NA trial testing Cough method for placement of tenaculum in Pain in 66 participants. Completed in 23 February 2017.

Timeline

10 January 2016

Primary endpoint
23 February 2017

23 February 2017

Quick facts

Lead sponsor	Duke University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	66
Start date	10 January 2016
Primary completion	23 February 2017
Estimated completion	23 February 2017

Drugs / interventions tested

Cough method for placement of tenaculum
Slow Tenaculum Placement of tenaculum

Conditions studied

Pain — all drugs for Pain →

Sponsor

Duke University

Who can join

Adults 18 to 55, female only, with Pain. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Pain With Tenaculum Placement Primary · Directly after tenaculum placement

Measured using 100-mm visual analog scale. Minimum value 0 meaning no pain and maximum value of 100 meaning worst imaginable pain.

Group	Value	95% CI
Slow Tenaculum Placement	44	21 – 63
Cough Method	32	19 – 54

Overall Pain With Intrauterine Device Insertion Secondary · Directly after intrauterine device is placed

Measured using 100-mm visual analog scale. Minimum value 0 meaning no pain and maximum value of 100 meaning worst imaginable pain.

Group	Value	95% CI
Slow Tenaculum Placement	62	48 – 84
Cough Method	54	32 – 71

Provider Satisfaction With Tenaculum Placement Secondary · Directly after tenaculum is placed

Measured using Likert-type 5 point satisfaction scale dichotomized to optimal (Likert score = 4 or 5) vs suboptimal (Likert score = 1, 2, 3). Reported is the number of participants with optimal grasp.

Group	Value	95% CI
Slow Tenaculum Placement	26
Cough Method	27

Sponsor's own description

Randomized controlled trial that compares methods of tenaculum placement during intrauterine device insertion and their effect on pain. The two methods being compared are slow tenaculum placement versus tenaculum placement at time of cough. Subjects will be asked to rate their pain using visual analog scale. Primary outcome measured is pain at time of tenaculum placement. Secondary outcomes are overall pain with intrauterine device insertion and provider satisfaction with tenaculum placement.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pain perception with cervical tenaculum placement during intrauterine device insertion: a randomised controlled trial.
Lambert T, Truong T, Gray B. · · 2020 · cited 8× · PMID 31666302 · DOI 10.1136/bmjsrh-2019-200376

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting

Other Duke University trials

Trials by the same sponsor.

NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02969421 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 18 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02969421.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing